Francis Knuettel II

CHRO CEO purchased 5,200 shares at $0.97 across 2 transactions (Sep 10-13); stock at $8.50, down 82.3% from 52-week high.

Francis Knuettel II, serving as CEO, President, CFO, Treasurer and Secretary, executed 2 separate purchases totaling 5,200 shares for $5,044.00 at $0.97 per share on 2024-09-12 and 2024-09-13, adding 1.0% to his 542.5K share baseline. The stock currently trades at $8.50, representing an 82.3% decline from its 52-week high of $48.00, although it has recovered 7.6% over the prior 30 days. The company reported net income of -$1,771,619.00 for its most recent full fiscal year. Knuettel's cross-ticker track record shows only 2 prior open-market buys, and prior trades at CHRO (executed on 2024-09-10 and 2024-09-11) remain too recent for outcome measurement. The purchases occurred during a period of significant stock weakness, though without scheduled trading plan documentation, timing cannot be characterized as either well-timed or discretionary conviction.

CEO/CFO Francis Knuettel II buys 12,000 shares at $0.91 blended price vs. current $9.80 (stock -79.6% from 52-week high)

Francis Knuettel II, holding multiple executive roles (CEO, President, CFO, Treasurer, Secretary), purchased 12,000 shares across 2 separate transactions on 2024-09-10 and 2024-09-11 at a blended average price of $0.91, increasing his holdings from 530.5K to 542.5K shares (+2.3%). The timing is notable: Chromocell is unprofitable (net income of $-1.8M) and currently trades at $9.80, representing a steep 79.6% decline from its 52-week high of $48.00. The stock has rebounded +28.1% over the prior 30 days but remains -24.6% over 90 days. This is his first prior buy on record across his open-market history, limiting the ability to assess his execution pattern at this ticker or cross-ticker. The magnitude of the position increase (+2.3%) combined with material execution at distressed price levels during a period of significant stock volatility warrants monitoring of whether this reflects a point-of-confidence decision by a multi-hat executive or a temporary technical bounce in a fundamentally challenged name.